Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jun 2026 for NeuPath Health Inc., €7,773. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Daniel Chicoine: trading record in brief
This profile gathers the share dealings of Daniel Chicoine across 2 companies, led by Crescita Therapeutics Inc. and NeuPath Health Inc. In total, 12 filings cover trades dated from 6 May 2024 to 15 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 15 June 2026, the filings show a transaction worth €7,773 in NeuPath Health Inc. Between a trade and the moment it shows up on SEDI, the median delay is 5 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel Chicoine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
20,000 shares@ CA$0.63100.0% of flowCommon SharesTSXSEDI:4735702
20,000 sharesRestricted Share Unit (RSU)TSXSEDI:4735700
50,000 sharesRestricted Share Unit (RSU)TSXSEDI:4735698
59,158 sharesOptionsTSXSEDI:4732052
632,000 shares@ CA$0.8035.4% of flowOptionsTSXSEDI:4732051
95,273 shares@ CA$0.805.3% of flowDeferred Share Units (DSU)TSXSEDI:4732050
124,879 shares@ CA$0.807.0% of flowCommon SharesTSXSEDI:4732042
11,900 shares@ CA$0.800.7% of flowCommon SharesTSXSEDI:4732041
116,227 shares@ CA$0.806.5% of flowCommon SharesTSXSEDI:4732040
38,795 shares@ CA$0.802.2% of flowCommon SharesTSXSEDI:4732039
119,577 shares@ CA$0.806.7% of flowCommon SharesTSXSEDI:4732038
645,999 shares@ CA$0.8036.2% of flowCommon SharesTSXSEDI:4732037
12 of 12 declarations
